With painkiller addiction on the rise.


However, not every ‘abuse-deterrent’ style offers received a regulatory thumbs-up. On 23 June, only a few days following the Oxecta approval, the FDA rejected Remoxy due to manufacturing problems. Remi Barbier, president and ceo of Discomfort Therapeutics in Austin, Texas, which developed the medication with Pfizer, says the firms are working to solve those issues now.) Picture: by Flickr user Be.Futureproof under Creative Commons.. With painkiller addiction on the rise, drugmakers attended up with clever methods to discourage such behavior.It really is a challenging time of year for those attempting to control and invert our nation’s obesity epidemic. Luckily that is an opportune period to remind everyone of the issue and discuss ideas and projects to fight obesity, in children especially, relating to organizers of the annual 15-condition Southern Obesity Summit. The 2008 gathering will end up being held Nov. 9-11 at the Birmingham-Jefferson Convention Complex. Researchers and educators at the University of Alabama at Birmingham , a summit host, will welcome healthcare professionals and academic, federal government and scientific leaders to develop and share strategies for fighting obesity.